These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2154781)

  • 1. Coupling of mu-opioid receptors with adenylate cyclase in naive and morphine tolerant rabbits.
    Polastron J; Boyer MJ; Thouvenot JP; Meunier JC; Jauzac P
    Prog Clin Biol Res; 1990; 328():25-8. PubMed ID: 2154781
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS; Tallman JF; Nestler EJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of binding affinities and adenylate cyclase inhibition for the determination of efficacy at mu-opioid receptors in a neuroblastoma cell line.
    Toll L
    NIDA Res Monogr; 1990; 105():520-1. PubMed ID: 1652090
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of adenyl cyclase in opiate tolerance and dependence.
    Klee WA; Milligan G; Simonds WF; Tocque B
    NIDA Res Monogr; 1984; 54():109-18. PubMed ID: 6152484
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different subtypes of opioid receptors have different affinities for G-proteins.
    Polastron J; Jauzac P
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mixed-action opioids on food-maintained behavior of morphine-pretreated and morphine-tolerant rats.
    Oliveto A; Picker M; Dykstra LA
    NIDA Res Monogr; 1989; 95():524. PubMed ID: 2561847
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F; Cox BM
    Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
    Yu VC; Sadée W
    J Pharmacol Exp Ther; 1988 Apr; 245(1):350-5. PubMed ID: 2834542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M; Boda K; Gintzler AR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines.
    Law PY; Koehler JE; Loh HH
    Mol Pharmacol; 1982 Mar; 21(2):483-91. PubMed ID: 6285173
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical reactions between opiate receptor binding and inhibition of neurotransmission.
    Clouet DH; Yonehara N
    NIDA Res Monogr; 1984; 54():95-108. PubMed ID: 6099882
    [No Abstract]   [Full Text] [Related]  

  • 15. Receptor-mediated inhibitions of NG108-15 adenylate cyclase: essential role of Na+ and GTP.
    Blume AJ; Lichtshtein D; Boone G
    Adv Biochem Psychopharmacol; 1980; 21():339-48. PubMed ID: 6246750
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
    Xu H; Lu YF; Rothman RB
    Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein.
    Wang HY; Burns LH
    J Neurobiol; 2006 Oct; 66(12):1302-10. PubMed ID: 16967511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    Carter BD; Medzihradsky F
    Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain.
    He L; Whistler JL
    Pharmacology; 2007; 79(4):193-202. PubMed ID: 17356311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.